IMPROVED SURVIVAL DURATION WITH COMBINATION CHEMOTHERAPY INDUCTION FOR MULTIPLE-MYELOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY

被引：87
|
作者：
DURIE, BGM
DIXON, DO
CARTER, S
STEPHENS, R
RIVKIN, S
BONNET, J
SALMON, SE
DABICH, L
FILES, JC
COSTANZI, JJ
机构：
[1] UNIV ARIZONA,ARIZONA MED CTR,TUCSON,AZ 85724
[2] SW ONCOL GRP,CTR BIOSTAT,HOUSTON,TX
[3] UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103
[4] PUGET SOUND ONCOL CONSORTIUM,SEATTLE,WA
[5] SCOTT & WHITE CLIN,TEMPLE,TX
[6] UNIV MICHIGAN,ANN ARBOR,MI 48109
[7] UNIV MISSISSIPPI,MED CTR,JACKSON,MS 39216
[8] UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 08期
关键词：
D O I：
10.1200/JCO.1986.4.8.1227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1227 / 1237
页数：11
相关论文
共 50 条
  • [21] PHASE-II INVESTIGATION OF PENTOSTATIN IN MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP-STUDY
    GREVER, MR
    CROWLEY, J
    SALMON, S
    MCGEE, R
    KRAUT, EH
    BUYS, SS
    RIVKIN, SE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (22) : 1778 - 1779
  • [22] QUALITY OF SURVIVAL IN HISTIOCYTOSIS-X - A SOUTHWEST ONCOLOGY GROUP-STUDY
    KOMP, DM
    ELMAHDI, A
    STARLING, KA
    EASLEY, J
    VIETTI, TJ
    BERRY, DH
    GEORGE, SL
    MEDICAL AND PEDIATRIC ONCOLOGY, 1980, 8 (01): : 35 - 40
  • [23] VINCRISTINE, BCNU, DOXORUBICIN, AND PREDNISONE (VBAP) COMBINATION IN THE TREATMENT OF RELAPSING OR RESISTANT MULTIPLE-MYELOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BONNET, J
    ALEXANIAN, R
    SALMON, S
    BOTTOMLEY, R
    AMARE, M
    HAUT, A
    DIXON, D
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1267 - 1271
  • [24] EFFECT OF ALTERNATING COMBINATION CHEMOTHERAPY ON SURVIVAL OF AMBULATORY PATIENTS WITH METASTATIC LARGE-CELL AND ADENOCARCINOMA OF THE LUNG - A SOUTHWEST ONCOLOGY GROUP-STUDY
    MILLER, TP
    CHEN, TT
    COLTMAN, CA
    OBRYAN, RM
    VANCE, RB
    WEISS, GB
    FLETCHER, WS
    STEPHENS, RL
    LIVINGSTON, RB
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) : 502 - 508
  • [25] CHEMOTHERAPY IN MULTIPLE-MYELOMA - THE COMPA COMBINATION
    VAZQUEZVILLEGAS, V
    LAMAS, JLD
    ROMEROGARCIA, F
    RODRIGUEZCARRILLO, J
    MEDINARUIZ, F
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1989, 41 (04): : 345 - 350
  • [26] EFFICACY OF PREDNISONE IN REFRACTORY MULTIPLE-MYELOMA AND MEASUREMENT OF GLUCOCORTICOID RECEPTORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    GUPTA, V
    THOMPSON, EB
    STOCKNOVACK, D
    SALMON, SE
    PIERCE, HI
    BONNET, JD
    CHILTON, D
    BECKORD, J
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (02) : 121 - 128
  • [27] CYCLIC ALTERNATING COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA
    BUNN, P
    SCHECHTER, G
    IHDE, D
    COHEN, M
    BINDER, R
    MINNA, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 410 - 410
  • [28] COMBINATION CHEMOTHERAPY FOR TREATMENT OF ADVANCED MULTIPLE-MYELOMA
    BURNS, WI
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (02): : 187 - 187
  • [29] VAD CHEMOTHERAPY AS REMISSION INDUCTION FOR MULTIPLE-MYELOMA
    ANDERSON, H
    SCARFFE, JH
    RANSON, M
    YOUNG, R
    WIERINGA, GS
    MORGENSTERN, GR
    FITZSIMMONS, L
    RYDER, D
    BRITISH JOURNAL OF CANCER, 1995, 71 (02) : 326 - 330
  • [30] A PHASE-II TRIAL OF COMBINATION CHEMOTHERAPY IN PATIENTS WITH METASTATIC CARCINOID-TUMORS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BUKOWSKI, RM
    JOHNSON, KG
    PETERSON, RF
    STEPHENS, RL
    RIVKIN, SE
    NEILAN, B
    COSTANZI, JH
    CANCER, 1987, 60 (12) : 2891 - 2895
12345